Adverse events in low-dose naltrexone arm. by Judith I. Tsui (5983160)

“…Pain severity decreased for all three arms. Mean differences in change in pain severity for gabapentin vs. placebo, and naltrexone vs. placebo were -0.27 (95% confidence interval [CI] -1.76, 1.23; p = 0.73) and 0.88 (95% CI -0.7, 2.46; p = 0.55), respectively. …”

CONSORT flow diagram. by Judith I. Tsui (5983160)

“…Pain severity decreased for all three arms. Mean differences in change in pain severity for gabapentin vs. placebo, and naltrexone vs. placebo were -0.27 (95% confidence interval [CI] -1.76, 1.23; p = 0.73) and 0.88 (95% CI -0.7, 2.46; p = 0.55), respectively. …”

Adverse events in placebo arm. by Judith I. Tsui (5983160)

“…Pain severity decreased for all three arms. Mean differences in change in pain severity for gabapentin vs. placebo, and naltrexone vs. placebo were -0.27 (95% confidence interval [CI] -1.76, 1.23; p = 0.73) and 0.88 (95% CI -0.7, 2.46; p = 0.55), respectively. …”

Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

“…Pain severity decreased for all three arms. Mean differences in change in pain severity for gabapentin vs. placebo, and naltrexone vs. placebo were -0.27 (95% confidence interval [CI] -1.76, 1.23; p = 0.73) and 0.88 (95% CI -0.7, 2.46; p = 0.55), respectively. …”

UGGT activity decreases in <i>uggt-1(RNAi)</i> worms but no decrease was observed in <i>uggt-2 (RNAi)</i> worms. by Lucila I. Buzzi (198284)

Decreased brain-derived neurotrophic factor plasma levels in psoriasis patients by A.R. Brunoni (5694239)

Diabetes and TPEN treatment decreased the expression of Nrf2 that was associated with decreased Akt and GSK-3β phosphorylation and nuclear accumulation of Fyn. by Chi Zhang (9857)

The mean accuracy of the BVRT between under control (gray) and rTMS (black), for the design 1–3 (Simple), the designs 4–7 (Medium) and the designs 8–10 (Complex). by Nakako Okamoto (18501452)

NDP-MSH decreases Pam₃CSK₄-induced microglial phagocytosis of latex beads. by Lila Carniglia (348123)

Evaluation index results for the JS-10 phantom. by Masakazu Tsujimoto (22339504)

Subjects:

GIRK2^AgRP-KO mice show decreased EE associated with BAT dysfunction and decreased sympathetic activity. by Youjin Oh (3308670)

Mean pace of decrease in mortality rates for White (front row) and Black (back row) women for the thirteen U.S. states from 1975 through 2010. by Mohammad A. Tabatabai (630217)

Decreased Integrity, Content, and Increased Transcript Level of Mitochondrial DNA Are Associated with Keratoconus by Xiao-Dan Hao (215742)

“…The relative mtDNA content of KC corneas was significantly lower than that of normal corneas (<i>P</i> = 9.19×10⁻²⁴), possibly due to decreased expression of the mitochondrial transcription factor A (<i>TFAM</i>) gene (<i>P</i> = 3.26×10⁻³). …”

Pretreatment with SDG prevents iron induced decrease in H9c2 cell size. by Stephanie Puukila (568109)

Tim-3 deficiency enhances the levels of proinflammatory cytokines and decreases the parasite burden. by Houbao Qi (11996039)

Antitumor Activity of FGFR Inhibitor as a Result of a Decrease in the Breast TIC Subpopulation In Vivo. by Sungeun Kim (105743)

CXCL10 production is enhanced in the setting of HIV and HBV co-infection in vitro and decreased with the addition of antiretroviral agents efavirenz or raltegravir. by Kasha P. Singh (9354307)

Localization of key HH signaling proteins is impaired in <i>Ttbk2</i>^{<i>sca11/gt</i>} cilia. by Emily Bowie (543704)

Compatible pollen triggers a decrease in S-RNase transcript levels by a post-transcriptional mechanism. by Bolin Liu (59887)

Resveratrol decreases CYP17A1 and CYP21A2 protein expression. by Nesa Marti (3851059)